Holcomb John Bradley

Holcomb John Bradley is listed in filings as Director at MiNK Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including 4 public disclosures. Recent filings connect the profile to MiNK Therapeutics, Inc. (INKT). The current snapshot covers public activity from Dec 3, 2025 to Jun 2, 2026. Reported amounts are shown as $13.5K to $62.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.